Therapeutic potential of voltage gated calcium channels

Mini-Reviews in Medicinal Chemistry

Volumn 8, Issue 12, 2008, Pages 1285-1290

  Mohan, C Gopi ^a   Gandhi, Tamanna ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Calcium; Dihydropyridine; L type channel; T type channel; Voltage gated channel

Indexed keywords

AMLODIPINE; BENIDIPINE; BEPRIDIL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; CALCIUM CHANNEL R TYPE; CALCIUM CHANNEL T TYPE; CILNIDIPINE; CYCLOSPORIN; CYTOCHROME P450 2D6; DIGOXIN; DILTIAZEM; ERYTHROMYCIN; GALLOPAMIL; LACIDIPINE; MANIDIPINE; MIBEFRADIL; NEUROTRANSMITTER; NICARDIPINE; NIFEDIPINE; NIMODIPINE; NISOLDIPINE; SIMVASTATIN; TACROLIMUS; UNINDEXED DRUG; VERAPAMIL; VOLTAGE GATED CALCIUM CHANNEL;

ANKLE EDEMA; ANXIETY; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; BRAIN PERFUSION; CHANNEL GATING; CONSTIPATION; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG METABOLISM; DRUG RESEARCH; DRUG TARGETING; ELECTROLYTE BALANCE; EPILEPSY; EXCITATION CONTRACTION COUPLING; FLUSHING; HEADACHE; HEMODYNAMIC PARAMETERS; HORMONE RELEASE; HUMAN; HYPERTENSION; INSOMNIA; KIDNEY PERFUSION; LIPID BLOOD LEVEL; NEUROTRANSMITTER RELEASE; PAIN; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; SEDATION; SEXUAL FUNCTION; SIDE EFFECT; TACHYCARDIA; URIC ACID BLOOD LEVEL;

ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CALCIUM CHANNELS, L-TYPE; CALCIUM CHANNELS, N-TYPE; CALCIUM SIGNALING; CHEMISTRY, PHARMACEUTICAL; DRUG DESIGN; HUMANS; ION CHANNEL GATING; MODELS, BIOLOGICAL;

EID: 57149122201     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955708786141016     Document Type: Review

References (35)

1. Triggle, D.J. Eur. J. Pharmacol., 1999, 375, 311.
2. Perez-Reyes, E. Physiol. Rev., 2003, 83, 117.
3. Schaufele, N.; Diener, M. Life Sci., 2005, 77, 2489.
4. Van, P.F.; Minor, D.L.Jr. Biochem. Soc. Trans., 2006, 34, 887.
5. Catterall, W.A.; Striessnig, J.; Snutch, T.P.; Perez-Reyes, E. Pharmacol. Rev., 2003, 55, 579.
6. Brette, F.; Leroy, J.; Le-Guennec, J.Y.; Salle, L. Prog. Biophys. Mol. Biol., 2006, 91, 1.
7. Moosmang, S.; Lenhardt, P.; Haider, N.; Hofmann, F.; Wegener, J.W. Pharmacol. Ther., 2005, 106, 347.
8. Dolphin, A.C. Br. J. Pharmacol., 2006, 147(Suppl 1), S56-62.
9. Chen, Y.H.; Li, M.H.; Zhang, Y.; He, L.L.; Yamada, Y.; Fitzmaurice, A.; Shen, Y.; Zhang, H.; Tong, L.; Yang, J. Nature, 2004, 429, 675.
10. Lin-ling, H.; Yun, Z.; Yu-hang, C.; Yoichi, Y.; and Jian, Y.; Biophys. J., 2007, 93, 834.
11. Cribbs, L.L. Cell Calcium., 2006, 40, 221.
12. Nelson, M.T.; Patlak, J.B.; Worley, J.F.; Standen, N.B. Am. J. Physiol., 1990, 259, C3.
13. Triggle, D.J. Biochem. Pharmacol., 2007, 74, 1.
14. Catterall, W.A.; Perez-Reyes, E.; Snutch, T.P.; Striessnig, J. Pharmacol. Rev., 2005, 57, 411.
15. Moosmang, S.; Lenhardt, P.; Haider, N.; Hofmann, F.; Wegener, J.W. Pharmacol. Ther., 2005, 106, 347.
16. Hockerman, G.H.; Peterson, B.Z.; Johnson, B.D.; Catterall, W.A. Ann. Rev. Pharmacol. Toxicol., 1997, 37, 361.
17. Miljanich, G.P.; Ramachandran, J. Annu. Rev. Pharmacol. Toxicol., 1995, 35, 707.
18. Abernethy, D.R.; Schwartz, J.B. N. Engl. J. Med., 1999, 341, 1447.
19. Lee, Y.S.; Lee, B.H.; Park, S.J.; Kang, S.B.; Rhim, H.; Park, J.Y.; Lee, J.H.; Jeong, S.W.; Lee, J.Y. Bioorg. & Med. Chem. Lett., 2004, 14, 3379.
20. Gupta S.P. Top Heterocycl. Chem., 2006, 4, 251.
21. Loev, B,; Goodman, M.M.; Snadon, K.M.; Tedeschi, R.; Macko, E. J. Med. Chem., 1974, 17, 956.
22. Gaudio, A.C.; Korolkovas, A.; Takahata, Y. J. Pharm. Sci., 1994, 83, 1110.
23. Doddareddy, M.R.; Jung, H.K.; Lee, J.Y.; Lee, Y.S.; Cho, Y.S.; Koh, H.Y.; Pae, Y.N. Biorg. Med. Chem., 2004, 12, 1605.
24. Rhim, H.; Lee, Y.S.; Park, S.J.; Chung, B.Y.; Lee, J.Y. Biorg. Med. Chem. Lett. 2005, 15, 283.
25. Park, J.H.; Choi, J.K.; Lee, E.; Lee, J.K.; Rhim, H.; Seo, S.H.; Kim, Y.; Doddareddy, M.R.; Pae, A.N.; Kang, J.; Roh, E.J. Bioorg. Med. Chem., 2007, 15, 1409.
26. McGivern J.G.. CNS Neurol. Disord. Drug Targets, 2006, 5, 587.
27. Hemmateenejad, B.; Safarpour, M.A.; Miri, R.; Taghavi, F. J. Comput. Chem., 2004, 25, 1495.
28. Doddareddy, MR.; Jung, H.K.; Cha, J.H.; Cho, Y.S.; Koh, H.Y.; Chang, M.H.; Pae, A.N. Bioorg. Med. Chem. 2004, 12, 1613.
29. De-Paoli, P.; Cerbai, E.; Koidl, B.; Kirchengast, M.; Sartiani, L.; Mungelli, A. Pharmacol. Res., 2002, 46, 491.
30. Ertel, S.I.; Clozel, J.P. Expert. Opin. Investig. Drugs, 1997, 6, 569.
31. Bennett, M.A.; Thomyant, P.; Jiunn, H.L. Drug Metab. Dispos., 1999, 28, 125.
32. Wandel, C.; Kim, R.B.; Guengerich, F.P.; Wood, A.J. Drug Metab. Dispos., 2000, 28, 895.
33. Jung, H.K.; Doddareddy, M.R.; Cha, J.H.; Rhim, H.; Cho, Y.S.; Koh, H.Y.; Jung, B.Y.; Pae, A.N. Bioorg. Med. Chem., 2004, 12, 3965.
34. Mccalmont, W.F.; Heady, T.N.; Patterson, J.R.; Lindenmuth, M.A., Haverstick, D.M.; Gray, L.S. Macdonald, T.L. Bioorg. Med. Chem. Lett., 2004, 14, 3691.
35. Mcgivern, J.G. Drug Discov. Today, 2006, 11, 245.